In 2024, Rolfe OÜ had revenue of 3 thousand EUR and profit of 98 EUR. Beneficial owners: Ferli Retpap, Roland Retpap.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 3k € -55.8% | 6,8k € -19.3% | 8,4k € -19.1% |
Profit | 98 € -84.4% | 629 € +1158.0% | 50 € -97.6% |
Assets | - | - | - |
Liabilities | - | - | - |
Equity | 5,4k € +1.8% | 5,3k € +13.5% | 4,7k € +120.0% |
Employees | - | - | - |
Overall rating | B+76/100 |
Financial health | 85/100 |
Credit history | 70/100 |
Legal history | 100/100 |
Business activity | 35/100 |
| Overall risk | Low |
No risk flags | |
Possible tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | - |
Rolfe OÜ is located at Pärnu maakond, Põhja-Pärnumaa vald, Kõnnu küla, Kõnnumetsa, 87403.
In 2024, Rolfe OÜ had revenue of 2986 EUR and profit of 98 EUR. Compared to previous year, revenue decreased by 55.8%. View full financial report →
The beneficial owners of Rolfe OÜ are Ferli Retpap and Roland Retpap. View ownership details →
No, Rolfe OÜ does not have an active VAT number and is not registered as a VAT payer.
Rolfe OÜ was founded on August 21, 2020. The company has been operating for 6 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 6 years | 486 - 490 | 33% | |
Net revenue | 2986,00 € | 635 - 639 | 13% | |
Profit | 98,00 € | 412 - 416 | 43% | |
Equity | 5402,00 € | 540 - 544 | 19% | |
Liquidity | 2.28 | - | 75% | |
Profitability | 3.3% | - | 10% | |
Registered capital | 2500,00 € | - | 25% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Registered in the Estonian business register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| Ferli Retpap | - | 50.00% | |
| Roland Retpap | - | 50.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Ferli Retpap | EE | - | |
| Roland Retpap | EE | - |